US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Diabetic Peripheral Neuropathy-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Diabetic Peripheral Neuropathy. This report provides information on the therapeutic development based on the Diabetic Peripheral Neuropathy dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Drug Addiction-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Drug Addiction. This report provides information on the therapeutic development based on the Drug Addiction dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Post-Traumatic Stress Disorder (PTSD)-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Post-Traumatic Stress Disorder (PTSD). This report provides information on the therapeutic development based on the Post-Traumatic Stress Disorder (PTSD) dealing with all the pipeline drugs, comparative ...  |  read more...
USD 1,250
Psychosis-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Psychosis. This report provides information on the therapeutic development based on the Psychosis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
Recurrent Malignant Glioma-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Recurrent Malignant Glioma. This report provides information on the therapeutic development based on the Recurrent Malignant Glioma dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Recurrent Malignant Glioma -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... understanding for all the pipeline drugs that fall under Recurrent Malignant Glioma . This report provides information on the therapeutic development based on the Recurrent Malignant Glioma dealing with all the pipeline drugs, comparative analysis ...  |  read more...
USD 1,250
Seizures-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Seizures. This report provides information on the therapeutic development based on the Seizures dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
Tourette Syndrome-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Tourette Syndrome. This report provides information on the therapeutic development based on the Tourette Syndrome dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Traumatic Brain Injury-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Traumatic Brain Injury. This report provides information on the therapeutic development based on the Traumatic Brain Injury dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Treatment Resistant Depression-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... all the pipeline drugs that fall under Treatment Resistant Depression. This report provides information on the therapeutic development based on the Treatment Resistant Depression dealing with all the pipeline drugs, comparative analysis at various stages ...  |  read more...
USD 1,250
Intraoperative Neuromonitoring Market in the US 2015-2019
11/26/2014 | published by: TechNavio - Infiniti Research Ltd.
... be used in various surgical procedures including neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, cardiac surgery, genitourinary surgery, interventional radiological procedures, and other general surgeries. It plays a vital role in surgery to provide immediate ...  |  read more...
USD 2,500
High-Grade Glioma - Pipeline Review, H2 2014
12/15/2014 | published by: Global Markets Direct
... therapeutic development for High-Grade Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Depression Therapy & Treatment Market – Depression drugs and devices, Anxiety Disorders,  SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Psychoanalysis, Cognitive Behavior, Psychodynamic, Electroconvulsive Pipeline Analysis,
11/10/2014 | published by: Occams Business Research & Consultancy
... with friends/family and disinterest in activities that were pleasurable earlier, and in extreme cases, depressive patient even contemplates and/or attempts self-harm such as suicide. Depression is a very common mental disorder and over 350 million ...  |  read more...
USD 5,500
Young people’s mental health
11/20/2014 | published by: Emerald Group Publishing Limited
... now. As Gandhi stated: “If we are to teach real peace in this world and if we are to carry on a real war against war, we shall have to begin with the children.” In ...  |  read more...
USD 199
Neuroblastoma-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Neuroblastoma. This report provides information on the therapeutic development based on the Neuroblastoma dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
Diabetic Neuropathy-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Diabetic Neuropathy. This report provides information on the therapeutic development based on the Diabetic Neuropathy dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Traumatic Brain Injury Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Traumatic Brain Injury in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
Glioma Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Attention Deficit Hyperactivity Disorder Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... market. It covers emerging therapies for Attention Deficit Hyperactivity Disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying ...  |  read more...
USD 670
Central Nervous System Disorders Pipeline Highlights Database – 2015
11/5/2014 | published by: Fore Pharma
... Drug market. It covers emerging therapies for CNS indications in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Multiple Sclerosis, Depression, Alzheimer’s disease, Parkinson’s disease, ...  |  read more...
USD 2,800
Down Syndrome-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Down Syndrome. This report provides information on the therapeutic development based on the Down Syndrome dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Global Epilepsy Market 2014-2018
11/5/2014 | published by: TechNavio - Infiniti Research Ltd.
... brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying cause of the disease is unidentified, as occurs in majority of the cases, it is known as idiopathic epilepsy. Epilepsy ...  |  read more...
USD 2,500
Conference Documentation: Clinical Trials in CNS
11/11/2014 | published by: SMI Publishing, Ltd
... The economic and social costs of neurodegenerative disorders to society are huge. Many big pharmaceutical companies have moved away from CNS research. With this comes the need for new and improved therapies for treating neurodegenerative ...  |  read more...
USD 788.78
Neuromodulation Devices: World Industry and Market 2015-2025
11/10/2014 | published by: Visiongain
... treatments hold high potential. Now you can explore sales forecasts and explore that industry’s research and development (R&D). Visiongain’s new report predicts those revenues to 2025 at overall world market, submarket and national level. There ...  |  read more...
USD 2,914
General Anxiety Disorder - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... information on the therapeutic development for General Anxiety Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
1  2    4    6  7  8  9  10